Home › Funds › GUGGENHEIM CAPITAL LLC › GILD
GUGGENHEIM CAPITAL LLC position in GILD
GILEAD SCIENCES INC · Health Care
GUGGENHEIM CAPITAL LLC reported holding 416,657 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$52.6M, representing 0.34% of its reported portfolio and ranking #49 among its reported holdings. GUGGENHEIM CAPITAL LLC has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GUGGENHEIM CAPITAL LLC's GILD position evolved
GUGGENHEIM CAPITAL LLC first disclosed a stake in GILD in Q3 2023 at 766,780 shares (US$57.5M). The position peaked in Q4 2025 at 517,789 shares, worth US$63.6M. Across 12 filings, GUGGENHEIM CAPITAL LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 416,657 shares valued at US$52.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 766.78K | $57.46M | New |
| Q4 2023 | 760.40K | $61.60M | Reduce |
| Q1 2024 | 695.90K | $50.97M | Reduce |
| Q2 2024 | 777.91K | $53.37M | Add |
| Q3 2024 | 681.49K | $57.14M | Reduce |
| Q4 2024 | 647.25K | $59.79M | Reduce |
| Q1 2025 | 531.22K | $59.52M | Reduce |
| Q2 2025 | 560.94K | $62.19M | Add |
| Q3 2025 | 528.86K | $58.70M | Reduce |
| Q4 2025 | 517.79K | $63.55M | Reduce |
| Q1 2026 | 416.45K | $58.04M | Reduce |
| Q2 2026 | 416.66K | $52.64M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on GUGGENHEIM CAPITAL LLC
FAQ
How long has GUGGENHEIM CAPITAL LLC held GILD?
GUGGENHEIM CAPITAL LLC has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is GUGGENHEIM CAPITAL LLC's current position in GILD?
As of Q2 2026, GUGGENHEIM CAPITAL LLC holds 416.66K shares of GILD (GILEAD SCIENCES INC), valued at $52.64M, representing 0.34% of its reported portfolio and ranking #49.
Has GUGGENHEIM CAPITAL LLC been buying or selling GILD?
In the latest 13F filing (Q2 2026), GUGGENHEIM CAPITAL LLC held unchanged its position in GILD. The position peaked in Q4 2025 at 517.79K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.